Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

The H1pdm09 subtype of the Influenza A virus continues to circulate in Armenia, along with other respiratory infections, ...

AN infectious disease expert at the University of Port Harcourt Teaching Hospital, Dr Chizaram Onyeaghala, has allayed the fears that Human metapneumovirus (HMPV) is extremely unlikely to be the next ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

Yellow fever infections are on the rise in several Americas countries, with the virus expanding its reach outside the zone ...

A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a ...

School closures reduced the impact of COVID-19 in most countries but had negative effects in some, Monash University-led ...

To see how the coronavirus that causes COVID-19, SARS-CoV-2, might affect coronary arteries that supply blood to the heart, ...

New Jersey-based biotechnology company, Grignard Pure LLC, a leader in developing next-generation indoor air treatment solutions for disease mitigation, indoor air quality and pandemic response, is ...

Doctors have found that Covid-19's inflammation can cause long-term cardiovascular issues, such as accelerated plaque buildup ...